Scynexis Inc (SCYX)
0.9718 x 4 0.9800 x 19
Post-market by (Cboe BZX)
0.9726 -0.0474 (-4.65%) 04/28/25 [NASDAQ]
0.9718 x 4 0.9800 x 19
Post-market 0.9726 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | SCYX | KPTI | NRXP | ||
| Company | Scynexis Inc | Karyopharm Therapeut | Nrx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.0000 | 5.58 | 2.11 | ||
| High | 1.0000 | 6.32 | 2.11 | ||
| Low | 0.9410 | 5.52 | 2.01 | ||
| Last | 0.9726 | 6.07 | 2.10 | ||
| Change | -0.0474 | +0.45 | +0.03 | ||
| % Change | -4.65% | +8.01% | +1.45% | ||
| Volume | 188,525 | 133,530 | 58,646 | ||
| 20-Day Average Volume | 116,426 | 133,967 | 118,967 | ||
| Previous Close | 1.0200 | 5.62 | 2.07 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9211 | 4.64 | 1.93 | ||
| 20-Day Raw Stochastic | 65.73% | 83.93% | 92.86% | ||
| 20-Day Relative Strength | 50.19% | 52.42% | 50.71% | ||
| Weighted Alpha | -60.78 | -56.26 | -65.52 | ||
| Today's Opinion | 80% Sell | 72% Sell | 8% Sell | ||
| Previous Opinion | 64% Sell | 72% Sell | 8% Sell | ||
| Last Month's Opinion | 80% Sell | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.72% since 04/21/25 | +12.41% since 04/21/25 | +12.30% since 04/21/25 | ||
| Low | 0.9289 on 04/22/25 | 5.39 on 04/22/25 | 1.88 on 04/22/25 | ||
| High | 1.0999 on 04/25/25 | 6.56 on 04/23/25 | 2.11 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -2.74% since 03/28/25 | +45.91% since 03/28/25 | +3.45% since 03/28/25 | ||
| Low | 0.7284 on 04/07/25 | 3.51 on 04/01/25 | 1.58 on 04/07/25 | ||
| High | 1.0999 on 04/25/25 | 6.56 on 04/23/25 | 2.14 on 04/14/25 | ||
| 3-Month | |||||
| %Chg | -5.57% since 01/28/25 | -40.66% since 01/28/25 | -40.85% since 01/28/25 | ||
| Low | 0.7284 on 04/07/25 | 3.51 on 04/01/25 | 1.58 on 04/07/25 | ||
| High | 1.2450 on 02/11/25 | 10.47 on 01/30/25 | 3.65 on 01/29/25 | ||
| 6-Month | |||||
| %Chg | -31.51% since 10/28/24 | -55.04% since 10/28/24 | +62.79% since 10/28/24 | ||
| Low | 0.7284 on 04/07/25 | 3.51 on 04/01/25 | 1.12 on 11/14/24 | ||
| High | 1.4900 on 01/02/25 | 16.95 on 10/31/24 | 6.01 on 01/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,744 | 33,079 | 30,280 | ||
| Shares Outstanding, K | 38,981 | 8,570 | 16,916 | ||
| Annual Sales | 3,750,000 | 145,240,000 | 0 | ||
| Annual Net Income | -21,290,000 | -76,420,000 | -25,130,000 | ||
| Last Quarter Sales | 980,000 | 30,540,000 | 0 | ||
| Last Quarter Net Income | -4,430,000 | -30,780,000 | -9,080,000 | ||
| 60-Month Beta | 1.71 | 0.58 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 03/12/25 | -3.60 on 02/19/25 | -0.30 on 03/14/25 | ||
| Latest Earnings Date | 05/14/25 | 05/14/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||